[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |
Advanced search

United States Drugs for Osteoarthritis Pain Market Report 2017

January 2017 | 115 pages | ID: UE09161F91CEN
QYResearch

US$ 3,800.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Notes:

Sales, means the sales volume of Drugs for Osteoarthritis Pain

Revenue, means the sales value of Drugs for Osteoarthritis Pain

This report studies sales (consumption) of Drugs for Osteoarthritis Pain in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering
  • Abbott Laboratories
  • Johnson & Johnson
  • Novartis International
  • Pfizer
  • AbbVie
  • Abiogen Pharma
  • Afferent Pharmaceuticals
  • Astellas Pharma
  • BioDelivery Sciences International
  • CrystalGenomics
  • Cytori Therapeutics
  • Daiichi Sankyo
  • Eli Lilly
  • Endo Pharmaceuticals Holdings
  • Horizon Pharma
  • ICeutica
  • Iroko Pharmaceuticals
  • Merck
  • Nuvo Research
  • Regeneron Pharmaceuticals
  • Sanofi
  • SantoSolve
  • Techfields Pharma
  • Winston Pharmaceuticals
  • Yooyoung Pharmaceutical
  • Zynerba Pharmaceuticals
Market Segment by States, covering
  • California
  • Texas
  • New York
  • Florida
  • Illinois
Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into
  • OTC
  • Prescription
Split by applications, this report focuses on sales, market share and growth rate of Drugs for Osteoarthritis Pain in each application, can be divided into
  • Hospital
  • Clinics
  • Household
United States Drugs for Osteoarthritis Pain Market Report 2017

1 DRUGS FOR OSTEOARTHRITIS PAIN OVERVIEW

1.1 Product Overview and Scope of Drugs for Osteoarthritis Pain
1.2 Classification of Drugs for Osteoarthritis Pain
  1.2.1 OTC
  1.2.2 Prescription
1.3 Application of Drugs for Osteoarthritis Pain
  1.3.1 Hospital
  1.3.2 Clinics
  1.3.3 Household
1.4 United States Market Size Sales (Volume) and Revenue (Value) of Drugs for Osteoarthritis Pain (2011-2021)
  1.4.1 United States Drugs for Osteoarthritis Pain Sales and Growth Rate (2011-2021)
  1.4.2 United States Drugs for Osteoarthritis Pain Revenue and Growth Rate (2011-2021)

2 UNITED STATES DRUGS FOR OSTEOARTHRITIS PAIN COMPETITION BY MANUFACTURERS

2.1 United States Drugs for Osteoarthritis Pain Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Drugs for Osteoarthritis Pain Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Drugs for Osteoarthritis Pain Average Price by Manufactures (2015 and 2016)
2.4 Drugs for Osteoarthritis Pain Market Competitive Situation and Trends
  2.4.1 Drugs for Osteoarthritis Pain Market Concentration Rate
  2.4.2 Drugs for Osteoarthritis Pain Market Share of Top 3 and Top 5 Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion

3 UNITED STATES DRUGS FOR OSTEOARTHRITIS PAIN SALES (VOLUME) AND REVENUE (VALUE) BY STATES (2011-2016)

3.1 United States Drugs for Osteoarthritis Pain Sales and Market Share by States (2011-2016)
3.2 United States Drugs for Osteoarthritis Pain Revenue and Market Share by States (2011-2016)
3.3 United States Drugs for Osteoarthritis Pain Price by States (2011-2016)

4 UNITED STATES DRUGS FOR OSTEOARTHRITIS PAIN SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (2011-2016)

4.1 United States Drugs for Osteoarthritis Pain Sales and Market Share by Type (2011-2016)
4.2 United States Drugs for Osteoarthritis Pain Revenue and Market Share by Type (2011-2016)
4.3 United States Drugs for Osteoarthritis Pain Price by Type (2011-2016)
4.4 United States Drugs for Osteoarthritis Pain Sales Growth Rate by Type (2011-2016)

5 UNITED STATES DRUGS FOR OSTEOARTHRITIS PAIN SALES (VOLUME) BY APPLICATION (2011-2016)

5.1 United States Drugs for Osteoarthritis Pain Sales and Market Share by Application (2011-2016)
5.2 United States Drugs for Osteoarthritis Pain Sales Growth Rate by Application (2011-2016)
5.3 Market Drivers and Opportunities

6 UNITED STATES DRUGS FOR OSTEOARTHRITIS PAIN MANUFACTURERS PROFILES/ANALYSIS

6.1 Abbott Laboratories
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Drugs for Osteoarthritis Pain Product Type, Application and Specification
    6.1.2.1 OTC
    6.1.2.2 Prescription
  6.1.3 Abbott Laboratories Drugs for Osteoarthritis Pain Sales, Revenue, Price and Gross Margin (2011-2016)
  6.1.4 Main Business/Business Overview
6.2 Johnson & Johnson
  6.2.2 Drugs for Osteoarthritis Pain Product Type, Application and Specification
    6.2.2.1 OTC
    6.2.2.2 Prescription
  6.2.3 Johnson & Johnson Drugs for Osteoarthritis Pain Sales, Revenue, Price and Gross Margin (2011-2016)
  6.2.4 Main Business/Business Overview
6.3 Novartis International
  6.3.2 Drugs for Osteoarthritis Pain Product Type, Application and Specification
    6.3.2.1 OTC
    6.3.2.2 Prescription
  6.3.3 Novartis International Drugs for Osteoarthritis Pain Sales, Revenue, Price and Gross Margin (2011-2016)
  6.3.4 Main Business/Business Overview
6.4 Pfizer
  6.4.2 Drugs for Osteoarthritis Pain Product Type, Application and Specification
    6.4.2.1 OTC
    6.4.2.2 Prescription
  6.4.3 Pfizer Drugs for Osteoarthritis Pain Sales, Revenue, Price and Gross Margin (2011-2016)
  6.4.4 Main Business/Business Overview
6.5 AbbVie
  6.5.2 Drugs for Osteoarthritis Pain Product Type, Application and Specification
    6.5.2.1 OTC
    6.5.2.2 Prescription
  6.5.3 AbbVie Drugs for Osteoarthritis Pain Sales, Revenue, Price and Gross Margin (2011-2016)
  6.5.4 Main Business/Business Overview
6.6 Abiogen Pharma
  6.6.2 Drugs for Osteoarthritis Pain Product Type, Application and Specification
    6.6.2.1 OTC
    6.6.2.2 Prescription
  6.6.3 Abiogen Pharma Drugs for Osteoarthritis Pain Sales, Revenue, Price and Gross Margin (2011-2016)
  6.6.4 Main Business/Business Overview
6.7 Afferent Pharmaceuticals
  6.7.2 Drugs for Osteoarthritis Pain Product Type, Application and Specification
    6.7.2.1 OTC
    6.7.2.2 Prescription
  6.7.3 Afferent Pharmaceuticals Drugs for Osteoarthritis Pain Sales, Revenue, Price and Gross Margin (2011-2016)
  6.7.4 Main Business/Business Overview
6.8 Astellas Pharma
  6.8.2 Drugs for Osteoarthritis Pain Product Type, Application and Specification
    6.8.2.1 OTC
    6.8.2.2 Prescription
  6.8.3 Astellas Pharma Drugs for Osteoarthritis Pain Sales, Revenue, Price and Gross Margin (2011-2016)
  6.8.4 Main Business/Business Overview
6.9 BioDelivery Sciences International
  6.9.2 Drugs for Osteoarthritis Pain Product Type, Application and Specification
    6.9.2.1 OTC
    6.9.2.2 Prescription
  6.9.3 BioDelivery Sciences International Drugs for Osteoarthritis Pain Sales, Revenue, Price and Gross Margin (2011-2016)
  6.9.4 Main Business/Business Overview
6.10 CrystalGenomics
  6.10.2 Drugs for Osteoarthritis Pain Product Type, Application and Specification
    6.10.2.1 OTC
    6.10.2.2 Prescription
  6.10.3 CrystalGenomics Drugs for Osteoarthritis Pain Sales, Revenue, Price and Gross Margin (2011-2016)
  6.10.4 Main Business/Business Overview
6.11 Cytori Therapeutics
6.12 Daiichi Sankyo
6.13 Eli Lilly
6.14 Endo Pharmaceuticals Holdings
6.15 Horizon Pharma
6.16 ICeutica
6.17 Iroko Pharmaceuticals
6.18 Merck
6.19 Nuvo Research
6.20 Regeneron Pharmaceuticals
6.21 Sanofi
6.22 SantoSolve
6.23 Techfields Pharma
6.24 Winston Pharmaceuticals
6.25 Yooyoung Pharmaceutical
6.26 Zynerba Pharmaceuticals

7 DRUGS FOR OSTEOARTHRITIS PAIN MANUFACTURING COST ANALYSIS

7.1 Drugs for Osteoarthritis Pain Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Drugs for Osteoarthritis Pain

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Drugs for Osteoarthritis Pain Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Drugs for Osteoarthritis Pain Major Manufacturers in 2015
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES DRUGS FOR OSTEOARTHRITIS PAIN MARKET FORECAST (2016-2021)

11.1 United States Drugs for Osteoarthritis Pain Sales, Revenue Forecast (2016-2021)
11.2 United States Drugs for Osteoarthritis Pain Sales Forecast by Type (2016-2021)
11.3 United States Drugs for Osteoarthritis Pain Sales Forecast by Application (2016-2021)
11.4 Drugs for Osteoarthritis Pain Price Forecast (2016-2021)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

Methodology
Analyst Introduction
Data Source

The report requires updating with new data and is sent in 2-3 business days after order is placed.
LIST OF TABLES AND FIGURES

Figure Picture of Drugs for Osteoarthritis Pain
Table Classification of Drugs for Osteoarthritis Pain
Figure United States Sales Market Share of Drugs for Osteoarthritis Pain by Type in 2015
Figure OTC Picture
Figure Prescription Picture
Table Application of Drugs for Osteoarthritis Pain
Figure United States Sales Market Share of Drugs for Osteoarthritis Pain by Application in 2015
Figure Hospital Examples
Figure Clinics Examples
Figure Household Examples
Figure United States Drugs for Osteoarthritis Pain Sales and Growth Rate (2011-2021)
Figure United States Drugs for Osteoarthritis Pain Revenue and Growth Rate (2011-2021)
Table United States Drugs for Osteoarthritis Pain Sales of Key Manufacturers (2015 and 2016)
Table United States Drugs for Osteoarthritis Pain Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Drugs for Osteoarthritis Pain Sales Share by Manufacturers
Figure 2016 Drugs for Osteoarthritis Pain Sales Share by Manufacturers
Table United States Drugs for Osteoarthritis Pain Revenue by Manufacturers (2015 and 2016)
Table United States Drugs for Osteoarthritis Pain Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Drugs for Osteoarthritis Pain Revenue Share by Manufacturers
Table 2016 United States Drugs for Osteoarthritis Pain Revenue Share by Manufacturers
Table United States Market Drugs for Osteoarthritis Pain Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Drugs for Osteoarthritis Pain Average Price of Key Manufacturers in 2015
Figure Drugs for Osteoarthritis Pain Market Share of Top 3 Manufacturers
Figure Drugs for Osteoarthritis Pain Market Share of Top 5 Manufacturers
Table United States Drugs for Osteoarthritis Pain Sales by States (2011-2016)
Table United States Drugs for Osteoarthritis Pain Sales Share by States (2011-2016)
Figure United States Drugs for Osteoarthritis Pain Sales Market Share by States in 2015
Table United States Drugs for Osteoarthritis Pain Revenue and Market Share by States (2011-2016)
Table United States Drugs for Osteoarthritis Pain Revenue Share by States (2011-2016)
Figure Revenue Market Share of Drugs for Osteoarthritis Pain by States (2011-2016)
Table United States Drugs for Osteoarthritis Pain Price by States (2011-2016)
Table United States Drugs for Osteoarthritis Pain Sales by Type (2011-2016)
Table United States Drugs for Osteoarthritis Pain Sales Share by Type (2011-2016)
Figure United States Drugs for Osteoarthritis Pain Sales Market Share by Type in 2015
Table United States Drugs for Osteoarthritis Pain Revenue and Market Share by Type (2011-2016)
Table United States Drugs for Osteoarthritis Pain Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Drugs for Osteoarthritis Pain by Type (2011-2016)
Table United States Drugs for Osteoarthritis Pain Price by Type (2011-2016)
Figure United States Drugs for Osteoarthritis Pain Sales Growth Rate by Type (2011-2016)
Table United States Drugs for Osteoarthritis Pain Sales by Application (2011-2016)
Table United States Drugs for Osteoarthritis Pain Sales Market Share by Application (2011-2016)
Figure United States Drugs for Osteoarthritis Pain Sales Market Share by Application in 2015
Table United States Drugs for Osteoarthritis Pain Sales Growth Rate by Application (2011-2016)
Figure United States Drugs for Osteoarthritis Pain Sales Growth Rate by Application (2011-2016)
Table Abbott Laboratories Basic Information List
Table Abbott Laboratories Drugs for Osteoarthritis Pain Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Abbott Laboratories Drugs for Osteoarthritis Pain Sales Market Share (2011-2016)
Table Johnson & Johnson Basic Information List
Table Johnson & Johnson Drugs for Osteoarthritis Pain Sales, Revenue, Price and Gross Margin (2011-2016)
Table Johnson & Johnson Drugs for Osteoarthritis Pain Sales Market Share (2011-2016)
Table Novartis International Basic Information List
Table Novartis International Drugs for Osteoarthritis Pain Sales, Revenue, Price and Gross Margin (2011-2016)
Table Novartis International Drugs for Osteoarthritis Pain Sales Market Share (2011-2016)
Table Pfizer Basic Information List
Table Pfizer Drugs for Osteoarthritis Pain Sales, Revenue, Price and Gross Margin (2011-2016)
Table Pfizer Drugs for Osteoarthritis Pain Sales Market Share (2011-2016)
Table AbbVie Basic Information List
Table AbbVie Drugs for Osteoarthritis Pain Sales, Revenue, Price and Gross Margin (2011-2016)
Table AbbVie Drugs for Osteoarthritis Pain Sales Market Share (2011-2016)
Table Abiogen Pharma Basic Information List
Table Abiogen Pharma Drugs for Osteoarthritis Pain Sales, Revenue, Price and Gross Margin (2011-2016)
Table Abiogen Pharma Drugs for Osteoarthritis Pain Sales Market Share (2011-2016)
Table Afferent Pharmaceuticals Basic Information List
Table Afferent Pharmaceuticals Drugs for Osteoarthritis Pain Sales, Revenue, Price and Gross Margin (2011-2016)
Table Afferent Pharmaceuticals Drugs for Osteoarthritis Pain Sales Market Share (2011-2016)
Table Astellas Pharma Basic Information List
Table Astellas Pharma Drugs for Osteoarthritis Pain Sales, Revenue, Price and Gross Margin (2011-2016)
Table Astellas Pharma Drugs for Osteoarthritis Pain Sales Market Share (2011-2016)
Table BioDelivery Sciences International Basic Information List
Table BioDelivery Sciences International Drugs for Osteoarthritis Pain Sales, Revenue, Price and Gross Margin (2011-2016)
Table BioDelivery Sciences International Drugs for Osteoarthritis Pain Sales Market Share (2011-2016)
Table CrystalGenomics Basic Information List
Table CrystalGenomics Drugs for Osteoarthritis Pain Sales, Revenue, Price and Gross Margin (2011-2016)
Table CrystalGenomics Drugs for Osteoarthritis Pain Sales Market Share (2011-2016)
Table Cytori Therapeutics Basic Information List
Table Daiichi Sankyo Basic Information List
Table Eli Lilly Basic Information List
Table Endo Pharmaceuticals Holdings Basic Information List
Table Horizon Pharma Basic Information List
Table ICeutica Basic Information List
Table Iroko Pharmaceuticals Basic Information List
Table Merck Basic Information List
Table Nuvo Research Basic Information List
Table Regeneron Pharmaceuticals Basic Information List
Table Sanofi Basic Information List
Table SantoSolve Basic Information List
Table Techfields Pharma Basic Information List
Table Winston Pharmaceuticals Basic Information List
Table Yooyoung Pharmaceutical Basic Information List
Table Zynerba Pharmaceuticals Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Drugs for Osteoarthritis Pain
Figure Manufacturing Process Analysis of Drugs for Osteoarthritis Pain
Figure Drugs for Osteoarthritis Pain Industrial Chain Analysis
Table Raw Materials Sources of Drugs for Osteoarthritis Pain Major Manufacturers in 2015
Table Major Buyers of Drugs for Osteoarthritis Pain
Table Distributors/Traders List
Figure United States Drugs for Osteoarthritis Pain Production and Growth Rate Forecast (2016-2021)
Figure United States Drugs for Osteoarthritis Pain Revenue and Growth Rate Forecast (2016-2021)
Table United States Drugs for Osteoarthritis Pain Production Forecast by Type (2016-2021)
Table United States Drugs for Osteoarthritis Pain Consumption Forecast by Application (2016-2021)
Table United States Drugs for Osteoarthritis Pain Sales Forecast by States (2016-2021)
Table United States Drugs for Osteoarthritis Pain Sales Share Forecast by States (2016-2021)

More Publications

Need Help?

Ask a Question

Market Reports

All Categories